---
figid: PMC6743629__cbm-16-3-415-1
figtitle: Simplified schematic of the RAS-RAF-MEK-ERK signaling pathway, the mutation
  sites and frequencies of key effectors, and their representative targeted inhibitors
organisms:
- Homo sapiens
- Mus musculus
- Canis lupus familiaris
organisms_ner:
- Mus musculus
- Canis lupus familiaris
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC6743629
filename: cbm-16-3-415-1.jpg
figlink: /pmc/articles/PMC6743629/figure/Figure1/
number: F1
caption: Simplified schematic of the RAS-RAF-MEK-ERK signaling pathway, the mutation
  sites and frequencies of key effectors, and their representative targeted inhibitors.
papertitle: Synergistic inhibition of MEK and reciprocal feedback networks for targeted
  intervention in malignancy.
reftext: Yanan Li, et al. Cancer Biol Med. 2019 Aug;16(3):415-434.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9155104
figid_alias: PMC6743629__F1
figtype: Figure
redirect_from: /figures/PMC6743629__F1
ndex: ff793bcb-df0f-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6743629__cbm-16-3-415-1.html
  '@type': Dataset
  description: Simplified schematic of the RAS-RAF-MEK-ERK signaling pathway, the
    mutation sites and frequencies of key effectors, and their representative targeted
    inhibitors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Grb2
  - Raf1
  - Araf
  - Mdk
  - .na.character
  - Map2k1
  - Map2k2
  - Ephb2
  - Mapk1
  - Mapk3
  - GRB2
  - HRAS
  - ARAF
  - MAPK1
  - KRAS
  - NRAS
  - ZHX2
  - BRAF
  - RAF1
  - XYLT2
  - SOS1
  - SOS2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK3
  - Tie
  - Ras85D
  - InR
  - Ras64B
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Raf
  - drk
  - Sos
  - Dsor1
  - Mtk
  - Low
  - Erk7
  - rl
  - GDP
  - Vemurafenib
  - Dabrafenib
  - Encorafenib
  - Sorafenib
  - Regorafenib
  - Trametinib
  - Cobimetinib
  - Binimetinib
  - PD-0325901
  - Selumetinib
  - C-1040
  - SCH772984
  - GDC-0994
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
---
